Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2013 | 03-2013 | 01-2013 | 12-2012 | 10-2012 | |
| Sales | 7,108 | 42 | 8,921 | 53 | 7,267 |
| Cost of Goods | 4,643 | 191 | 5,231 | 513 | 4,132 |
| Gross Profit | 2,465 | -149 | 3,690 | -460 | 3,135 |
| Operating Expenses | 3,737 | 4,604 | 3,454 | 8,048 | 2,502 |
| Operating Income | -629 | -4,562 | 467 | -7,995 | 765 |
| Interest Expense | 31 | 5 | 58 | 5 | 61 |
| Other Income | 4 | 956 | 1,909 | 2,541 | -6 |
| Pre-tax Income | -656 | -3,611 | 2,318 | -5,459 | 698 |
| Income Tax | -243 | N/A | 525 | N/A | 244 |
| Net Income Continuous | -413 | -3,611 | 1,793 | -5,459 | 454 |
| Net Income | $-413 | $-3,611 | $1,793 | $-5,459 | $454 |
| EPS Basic Total Ops | -0.11 | -10.58 | 0.48 | -15.87 | 0.12 |
| EPS Basic Continuous Ops | -0.11 | -11.45 | 0.48 | -19.00 | 0.12 |
| EPS Diluted Total Ops | -0.11 | -10.58 | 0.45 | -15.87 | 0.11 |
| EPS Diluted Continuous Ops | -0.11 | -11.45 | 0.44 | -19.00 | 0.11 |
| EBITDA(a) | $-510 | $-4,379 | $586 | $-7,810 | $898 |